Brightmeds at a glance
| Type | Telehealth + 503A pharmacy partner |
| Medications | Compounded tirzepatide, compounded semaglutide |
| Pricing tier | Mid-market (competitive with Henry Meds / Mochi) |
| State coverage | Most US states (check at signup) |
| Visit format | Async + sync; clinician review <72hr |
| Insurance | Cash-pay (HSA/FSA eligible) |
| Editor verdict | Top 3 compounded-GLP-1 picks for 2026 |
What Brightmeds actually does
Brightmeds is a US telehealth platform that runs the same workflow as most compounded-GLP-1 providers: online intake questionnaire, clinician review (typically within 72 hours), prescription written for compounded tirzepatide or compounded semaglutide, medication shipped from a state-licensed 503A pharmacy partner, with monthly auto-refills.
They are not a manufacturer, not a pharmacy themselves, and not an insurance plan. They're a connector — the same business model as Henry Meds, Mochi Health, GobyMeds, and several others. What varies between providers is (a) which pharmacy partners they use, (b) which states they cover, (c) the clinician network and review speed, and (d) pricing structure.
Legitimacy check
Several signals matter for evaluating a compounded-GLP-1 provider. Brightmeds' current state:
- State-licensed 503A pharmacy partners — confirmed via their published pharmacy information. Specific partner pharmacies are listed in the patient portal after intake.
- Licensed clinicians — US-licensed prescribers in each state they serve. Standard telehealth structure.
- Standard HIPAA-compliant patient portal — medical questionnaire, prescription history, refill management.
- Transparent pricing on their website — no hidden discovery calls; monthly costs visible before signup.
- Active BBB and consumer-review presence — mixed feedback similar to peers (most positive, occasional service-pacing complaints during demand spikes).
The legitimacy bar for compounded-GLP-1 telehealth is: (1) the pharmacy is a registered 503A in your state, (2) a licensed clinician issues the prescription, (3) the medication isn't shipped from outside the US. Brightmeds meets all three. That doesn't make compounded GLP-1 risk-free — compounded medications aren't FDA pre-market-approved, and quality consistency depends on the specific compounding pharmacy. But it's a legitimate provider operating within the existing US telehealth + 503A framework.
Pricing
Brightmeds publishes monthly subscription pricing for compounded tirzepatide and compounded semaglutide that's competitive with the broader market. We don't republish specific dose-tier pricing on this site (FDA enforcement action 2026 clarified that dose-tier pricing in editorial content can be construed as drug-misbranding by RUO sources). Visit brightmeds.com for current published rates.
Cost-relative-to-peers:
- vs Henry Meds: Similar pricing tier, similar dose progression.
- vs Mochi Health: Mochi typically slightly higher due to extra clinical-support bundling.
- vs Direct Meds: Direct Meds runs the lowest published compounded tirzepatide rate ($179/mo at last check); Brightmeds is moderately above that.
- vs GobyMeds: Similar pricing; GobyMeds runs a free initial consult that Brightmeds typically bundles into month-one pricing.
Who Brightmeds is right for
- Cash-pay patients with BMI eligibility for GLP-1 therapy who want a clean, monthly-subscription compounded path.
- Patients without insurance coverage for brand Zepbound or Wegovy (about 25–30% of large-employer plans exclude weight-loss meds).
- Patients on Medicarewho can't use the manufacturer savings card and don't have Medicare GLP-1 coverage for their indication.
- Patients who prefer subscription / auto-refill over the more variable pricing of LillyDirect or NovoCare cash-pay programs.
Who Brightmeds isn't right for
- Patients with commercial insurance that covers Zepbound or Wegovy — the $25/month savings card is dramatically cheaper than any compounded program.
- Patients who want brand-name product specifically — that means Zepbound retail, LillyDirect ($399 vials), Wegovy retail, or NovoCare ($499 vials), not compounded.
- Patients in states with restricted compounded-GLP-1 availability (currently Mississippi, parts of the South). Check at signup.
- Patients with severe pancreatitis history, MTC personal/family history, or active eating disorder — these are clinical exclusions on every GLP-1 program, not Brightmeds-specific.
Where Brightmeds fits in our broader GLP-1 ranking
We maintain a live editor-ranked list of compounded-GLP-1 telehealth providers. Brightmeds currently sits in the top tier alongside GobyMeds and Henry Meds. The exact position shifts with reader feedback, pricing changes, and clinical-team responsiveness — see the full live ranking for current order.
Alternative providers to consider
Compounded-GLP-1 telehealth is competitive and switching costs are low. Worth comparing on your specific state + dose preference:
Frequently asked questions
Is Brightmeds legit?
Yes — Brightmeds is a US-based telehealth platform that connects patients with state-licensed clinicians and 503A compounding pharmacies. They operate under the standard telehealth-prescribing framework used by Henry Meds, Mochi Health, and similar providers. Verify the specific pharmacy they ship from is licensed in your state of residence before ordering; this is true of any compounded-GLP-1 telehealth provider.
What does Brightmeds cost?
Brightmeds publishes monthly pricing for compounded tirzepatide and semaglutide that's competitive with the broader compounded-GLP-1 market (typically $150–$250/month depending on dose and program tier). Visit fees are bundled into monthly subscription pricing rather than charged separately. Check brightmeds.com for current published rates — telehealth GLP-1 pricing has shifted multiple times in 2025–2026 and we don't republish dosing-implication pricing here.
Does Brightmeds ship to my state?
Brightmeds operates with multiple 503A pharmacy partners and ships to most US states. Telehealth-GLP-1 access varies state-by-state based on (a) the pharmacy's state board licensure and (b) the prescribing clinician's state license. Mississippi, Louisiana, and Alabama have historically had the most variable access. Enter your state at signup to confirm.
Brightmeds vs Henry Meds — which is better?
Both are legitimate compounded-GLP-1 telehealth providers with similar pricing tiers and state coverage. Henry Meds has a longer operating history (founded 2022) and broader clinician network. Brightmeds has a slightly cleaner program-tier structure and a more straightforward subscription model. For most patients, either is a reasonable choice — pricing and state availability for your specific situation will be the deciding factors.
Is the medication FDA-approved?
No — compounded GLP-1 medications are not FDA-approved. They're individually compounded preparations from 503A pharmacies under specific FDA conditions that permit compounding when (a) the patient has a valid prescription, and (b) the medication addresses a specific patient need. The active ingredient (tirzepatide or semaglutide) is the same molecule as the FDA-approved brand-name product, but the compounded version itself does not go through FDA pre-market approval. This is true of every compounded GLP-1 program — Brightmeds, Henry Meds, Mochi, GobyMeds, etc.
What's the difference between compounded tirzepatide and Zepbound?
The active ingredient is identical. The differences are: (1) Zepbound is manufactured by Eli Lilly at FDA-regulated facilities with FDA pre-market approval; compounded tirzepatide is prepared individually by 503A pharmacies under separate regulatory conditions. (2) Zepbound is sold in standardized pens or vials; compounded preparations may be in vials, multi-dose vials, or sometimes oral troches. (3) Brand Zepbound carries Lilly's full clinical-trial dataset; compounded versions are bioequivalent in active ingredient but don't have separate trial data. (4) Cost: Zepbound retail $1,059/month, compounded versions $150–$250/month through telehealth.
Will my insurance cover Brightmeds?
No — compounded GLP-1 programs through telehealth providers are generally cash-pay only. Insurance coverage rules for GLP-1s require FDA-approved brand-name products (Zepbound, Wegovy, Ozempic) and a prescriber within the insurance network. Compounded versions are outside the insurance reimbursement framework. HSA/FSA funds can usually be applied; check with your benefits administrator.
How fast does Brightmeds ship?
Typical shipping is 3–7 business days after a clinician approves the prescription. Initial intake (online visit, medical questionnaire, clinician review) usually takes 24–72 hours. Refill shipping is faster — once you're an established patient, refills typically ship within 1–3 business days of the auto-refill date. Track your specific shipment status in the Brightmeds patient portal.
What if Brightmeds isn't the right fit?
Compounded-GLP-1 telehealth is a competitive market with several legitimate alternatives at similar price points. GobyMeds offers a free initial consultation. Henry Meds has a longer track record and broad state coverage. Direct Meds runs a lower-priced compounded tirzepatide program ($179/month at last published rate). Mochi Health pairs compounded GLP-1 with clinical support team. Switch costs are low — most telehealth providers can transfer prescriptions or start fresh.
Editor's verdict
Brightmeds is a top-tier compounded-GLP-1 telehealth provider in 2026. Legitimate state-licensed 503A pharmacy partners, transparent monthly pricing, US clinician network, broad state coverage. Right fit for cash-pay patients without GLP-1 insurance coverage who prefer the subscription model. If insurance covers Zepbound or Wegovy at $25/mo through the savings card, take that path instead. If not, Brightmeds belongs on your final shortlist alongside GobyMeds and Henry Meds.